NEWS
NORMAN, OKLA. – The Executive Committee of Price College of Business Energy Institute Advisory Board welcomes Sandhya Ganapathy, chief executive officer of EDP Renewables North America and a member of the global EDP Renewables Management Team.
Ganapathy, who has extensive experience in the evaluation of renewable energy acquisitions and investments, joined the EDPR team in 2012, serving first as Head of Investment and M&A North America and Global Head of Investment and M&A before being named CEO in 2022. She holds a master’s degree in business administration from Carnegie Mellon and is a chartered accountant in India.
“I’m thrilled to join the Energy Institute Advisory Board and hope my experience and expertise in renewables can help shape the future of energy curriculum at the University of Oklahoma,” she said. “As a national leader in energy education, OU is developing the next generation of leaders to solve the most pressing energy challenges facing the globe in the 21st century.”
The Energy Advisory Board consists of thought leaders from various energy companies who play an influential role in the design of Price’s energy curriculum, especially Price’s 15-month hybrid Executive MBA in Energy program. The board ensures that the energy programs offered at the University of Oklahoma are relevant and incorporate the latest thinking in the fast-changing energy industry.
Learn more about EDPR North America, a top five owner and operator of renewable energy in North America, headquartered in Houston, TX.
About the University of Oklahoma
Founded in 1890, the University of Oklahoma is a public research university located in Norman, Oklahoma. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. OU was named the state’s highest-ranking university in U.S. News & World Report’s most recent Best Colleges list. For more information about the university, visit ou.edu.
The University of Oklahoma’s Native Nations Center for Tribal Policy Research recently released a new Sovereign Report titled “Purchased/Referred Care and Cancer: Overview and Options for Tribal Consideration.”
A powerful new $16 million cyclotron is arriving soon at the University of Oklahoma College of Pharmacy, marking a major expansion of advanced medical imaging, cancer treatment and research capabilities for patients across the state.
A $1.7 million grant from the National Institutes of Health will allow a University of Oklahoma researcher to continue investigating a protein that may help explain why Lupus develops and how it might be treated more precisely.
